Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biotest AG (GB:0N70)
LSE:0N70
Holding GB:0N70?
Track your performance easily
0N70 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€22.98 - €31.00
Previous Close€27.49
Volume0.00
Average Volume (3M)98.96K
Market Cap
€1.37B
Enterprise Value€1.80B
Total Cash (Recent Filing)€136.60M
Total Debt (Recent Filing)€574.30M
Price to Earnings (P/E)15.9
Beta0.10
Next Earnings
Mar 28, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 08, 2024Dividend Yield0.29%
Share Statistics
EPS (TTM)1.73
Shares OutstandingN/A
10 Day Avg. Volume10,012
30 Day Avg. Volume98,961
Standard Deviation0.06
R-Squared0.00090
Alpha0.00556
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)2.94
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
0N70 FAQ
What was Biotest AG’s price range in the past 12 months?
Biotest AG lowest share price was €22.98 and its highest was €31.00 in the past 12 months.
What is Biotest AG’s market cap?
Currently, no data Available
When is Biotest AG’s upcoming earnings report date?
Biotest AG’s upcoming earnings report date is Mar 28, 2025 which is in 125 days.
How were Biotest AG’s earnings last quarter?
Biotest AG released its earnings results on Nov 14, 2024. The company reported -€0.235 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.235.
Is Biotest AG overvalued?
According to Wall Street analysts Biotest AG’s price is currently Overvalued.
Does Biotest AG pay dividends?
Biotest AG pays a Notavailable dividend of €0.04 which represents an annual dividend yield of 0.29%. See more information on Biotest AG dividends here
What is Biotest AG’s EPS estimate?
Biotest AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biotest AG have?
Biotest AG has 19,785,727 shares outstanding.
What happened to Biotest AG’s price movement after its last earnings report?
Biotest AG reported an EPS of -€0.235 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Biotest AG?
Currently, no hedge funds are holding shares in GB:0N70
---
Biotest Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-11.06%
12-Months-Change
Fundamentals
Return on Equity
13.87%
Trailing 12-Months
Asset Growth
-0.21%
Trailing 12-Months
Company Description
Biotest AG
Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The operating business segments are Therapy, Plasma and Services, and Other segments. It generates maximum revenue from the Therapy segment. Geographically, it derives a majority of revenue from Central Europe and also has a presence in other countries.
---
Technical Analysis
HUTCHMED (China) Limited
―
PureTech Health
―
Creo Medical
―
Hikma Pharmaceuticals
―
---